期刊文献+

胸腔内注射重组人血管内皮抑素对裸鼠恶性胸腔积液的治疗作用 被引量:7

Therapeutical Effects of Pleural Injecting Recombinant Human Endostain to Malignant Pleural Effusion Nude Mice Model
下载PDF
导出
摘要 背景与目的恶性胸腔积液(malignant pleural effusion,MPE)临床预后不佳,胸腔内抗血管治疗可能对恶性胸腔积液具有治疗作用,本研究旨在探讨胸腔内注射重组人血管内皮抑素、顺铂、重组人血管内皮抑素联合顺铂对裸鼠恶性胸腔积液的治疗作用。方法 BALB/c裸鼠胸膜腔内注射Lewis肺癌细胞(Lewis lung cancer cell,LCC)构建恶性胸腔积液模型,造模后分别胸腔内注射重组人血管内皮抑素(E)、顺铂(P)以及重组人血管内皮抑素联合顺铂(EP)并分析各组裸鼠胸腔积液量、胸膜肿瘤微血管密度(micro vessel density,MVD)以及血管生成、凋亡相关基因的表达变化。结果重组人血管内皮抑素及重组人血管内皮抑素联合顺铂胸腔内注射可以使裸鼠MPE量减少,且与裸鼠胸腔肿瘤组织MVD下降呈正相关;且重组人血管内皮抑素及重组人血管内皮抑素联合顺铂胸腔内注射后,MPE裸鼠胸腔肿瘤组织血管内皮生长因子(Vescular epidermal growth factor-α,VEGF-α)表达下降、低氧诱导因子-α(hypoxia induced factor-1,HIF1-α)表达升高。结论胸腔内注射LLC细胞可成功制作裸鼠MPE模型。重组人血管内皮抑素裸鼠胸膜腔内注射对MPE裸鼠具有治疗作用,其治疗作用可能是通过下调VEGF-α,抑制肿瘤新生血管生成,下调微血管密度而达成的。 Background and objective hTe prognosis of malignant pleural effusion (MPE) was poor, injecting anti-angiogenesis agents in pleural cavity might be to reducing the volume of pleural effusion. hTe aim of this study is to investigate the therapeutical effect of pleural injection of recombinant human endostain, cisplatin and recombinant human endostain combined with cisplatin to MPE nude mice. Methods MPE model was built by intrpleural injection of Lewis lung cancer cells (LCC) into BALB/c nude mice. Intrpleural injection of recombinant human endostain (E), cisplatin (P) and recombinant hu-man endostain combined with cisplatin (EP) was performed, MPE volume was measured, immunohistochemistry of CD31 was carried out to calculate micro vessel density (MVD), angiogenesis and apoptosis gene expression was detected. Results MPE volume was reduced by intrapleiral injection of recombinant human endostain and recombinant human endostain com-bined with cisplatin, MPE volume was positive correlated with MVD. Vescular epidermal growth factor-α(VEGF-α) expression reduced simultaneously with expression of hypoxia induced factor-1 (HIF1-α) elevated at the same time. Conclusion MPE model could be made by intrapleural injection of LLC. Intrapleural injection of recombinant human endostain could reduce MPE volume of nude mice. hTe potential molecular mechanism of the therapeutical effects of intapleural injection of recombi-ant endostatin might be related to the downregulation of VEGF-αexpression and neovascularization.
出处 《中国肺癌杂志》 CAS CSCD 北大核心 2015年第5期266-271,共6页 Chinese Journal of Lung Cancer
基金 十二五国家科技支撑计划课题(No.2013BI09B09)资助~~
关键词 肺肿瘤 胸腔积液 重组人血管内皮抑素 Lung neoplasms Pleural effusion Recombinant human endostain
  • 相关文献

参考文献15

  • 1Underwood JM, Townsend JS, Tai E, et al. Racial and regional disparities in lung cancer incidence. Cancer, 2012, 118(7): 1910-1918. 被引量:1
  • 2Sakr L, Maldonado F, Greillier L, et al. Thoracoscopic assessment ofpleural tumor burden in patients with malignant pleural effusion: prognostic and therapeutic implications. J Thorac Oncol, 2011, 6(3): 592-597. 被引量:1
  • 3Kuzdzal J, Sladek K, Wasowski D, et al. Talc powder vs doxycycline in the control of malignant pleural effusion: a prospective, randomized trial. MedSci Monit, 2003, 9(6): PI54-59. 被引量:1
  • 4Shoji T, Tanaka F, Yanagihara K, et aL Phase II study of repeated intrapleu- ral chemotherapy using implantable access system for management of ma- lignant pleural effusion. Chest, 2002t 121 (3): 821-824. 被引量:1
  • 5Seto T, Ushijima S, Yamamoto H, et al. Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial. BrJ Cancer, 2006, 95(6): 717-721. 被引量:1
  • 6/Via X, Yao Y, Yuan D, et al. Recombinant human endostatin endostar sup- presses angiogenesis andl ymphangiogenesis of malignant pleural effusion in mice. PLoS One, 2012, 7(12): e53449. 被引量:1
  • 7Sabatino MA, Colombo T~ Geroni C, et al. Enhancement of in vivo antitu- mor activity of classical anticancer agents by combination with the new, glutathione-interacting DNA minor groove-binder, brostallicin. Clin Can- cer Res, 2003, 9 (14): 5402-5408. 被引量:1
  • 8Bertolini G, Roz L, Perego P, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Nag Acad Sci U S A, 2009, 106(38): 16281-16286. 被引量:1
  • 9Dong X, Guan J, English JC, et al. Patient-derived first generation xeno- grafts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res, 2010, 16(5): 1442-1451. 被引量:1
  • 10Stathopoulos GT, Zhu Z, Everhart MB, et al. Nuclear factor-kapp affects tumor progression in a mouse model of malignantpleural effusion. Am J Respir Cell Mol Biol, 2006, 34(2): 142-150. 被引量:1

同被引文献61

引证文献7

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部